Skip to content
WorkingMomRx
Menu

Evidence review

"Stomach Paralysis" on a GLP-1: The Part That Actually Changes What You Do

Slowed emptying is how these drugs work — the question is when it stops being therapeutic. Plus the surgery rule most people are never told about.

By Dana Whitfield, Managing Editora working mom, not a treating clinicianevery figure cited to its source
On this page

The short version

Search "stomach paralysis" and you mostly get law firms. Here is the practical shape of it.

Delayed gastric emptying is not a side effect of these drugs — it is part of how they work. They slow the stomach so you feel full longer. The clinical question is not whether it happens; it is when a therapeutic slowdown becomes a problem, and what you are supposed to do differently because of it.

There is one genuinely actionable thing in here that most people are never told, and it involves surgery. Skip to it if nothing else.

What is measured, versus what is claimed

The strongest recent evidence is not a case report. A 2026 prospective, multicentre, matched-control study used gastric ultrasound to look at what is actually in the stomachs of people taking semaglutide before anaesthesia1. That is direct measurement of retained contents in real patients rather than an inference from symptoms.

The broader picture: a systematic review and meta-analysis found gastrointestinal adverse events to be the dominant safety signal for GLP-1 receptor agonists across trials2, and a clinical review sets out the consequences of delayed gastric emptying with these drugs and tirzepatide specifically3.

What that supports: slowed emptying is real, measurable, and consequential in specific situations. What it does not support: that ordinary use routinely causes permanent gastroparesis. Those are different claims, and the second one is the one being advertised at you.

★ The surgery rule

This is the actionable part.

If your stomach empties slowly, a "nothing after midnight" fast may not empty it. Under anaesthesia, retained stomach contents can be regurgitated and inhaled — pulmonary aspiration — which is a serious complication. It has been reported in patients on semaglutide4, and it is why anaesthetists began paying attention to this class at all.

What to do: tell whoever is doing any procedure that involves sedation or anaesthesia that you take a GLP-1, and say it early — at booking, not on the morning. That includes procedures people do not think of as surgery: colonoscopy, endoscopy, dental sedation. Your anaesthetist may want a longer fast, a gastric ultrasound, or to hold doses beforehand. That is their call to make, and they can only make it if they know.

If you take one thing from this page, it is that sentence.

Symptoms: ordinary versus not

What you feelUsual readingWhat to do
Full quickly, smaller portionsExpected — it is the mechanismNothing
Nausea in the days after a dose stepCommon, tends to settleAsk about slowing titration
Vomiting food eaten many hours earlierNot ordinaryContact your clinician
Severe or persistent abdominal painNot ordinarySame-day contact
Unable to keep fluids downNot ordinary — dehydration riskSame-day contact
Symptoms that persist at a stable dose for weeksNot the usual patternGet it assessed properly

The pattern that matters is timing. Effects clustered around starting and around each dose increase, easing at a stable dose, is the expected course. Symptoms that arrive at a steady dose and do not settle are the ones worth investigating rather than tolerating.

What to actually ask for

  • Before any sedation or anaesthesia: disclose the drug at booking.
  • If symptoms track dose increases: ask to hold at the current dose longer. This is a normal request and a program that resists it is telling you something.
  • If symptoms persist at a stable dose: ask what would distinguish ordinary slowed emptying from something needing assessment, and what the threshold is for pausing.

Put the surgery line in your phone notes with your dose. You will be asked at the worst possible moment to remember it.

Frequently asked questions

Do GLP-1s cause stomach paralysis?

Delayed gastric emptying is part of how these medicines work — they slow the stomach so you stay full longer — and it is measurable: a 2026 prospective multicentre study used gastric ultrasound to assess retained stomach contents in patients taking semaglutide. That is different from the claim that ordinary use routinely causes permanent gastroparesis, which the evidence does not establish. Symptoms that persist at a stable dose, rather than clustering around dose increases, are the ones worth investigating.

Do I need to tell my surgeon or dentist I take a GLP-1?

Yes, and at booking rather than on the day. If the stomach empties slowly, a standard overnight fast may not empty it, and retained contents can be aspirated under anaesthesia — a complication reported in patients on semaglutide. This applies to anything with sedation, including colonoscopy, endoscopy and dental sedation. Your anaesthetist may want a longer fast, a gastric ultrasound, or doses held beforehand.

Which symptoms are not ordinary?

Vomiting food eaten many hours earlier, severe or persistent abdominal pain, and being unable to keep fluids down. Feeling full quickly and eating smaller portions is the intended mechanism. Nausea in the days after a dose increase is common and usually settles — symptoms that appear at a stable dose and do not settle are the ones to have assessed.

References

  1. Vlaeminck N, Van de Putte P, Dekeyser M, et al. (2026). Gastric ultrasound in patients receiving semaglutide: a prospective, multicentre, matched control study. Anaesthesia. https://pubmed.ncbi.nlm.nih.gov/41631344/
  2. Chiang CH, Jaroenlapnopparat A, Colak SC, et al. (2025). Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis. Gastroenterology. https://pubmed.ncbi.nlm.nih.gov/40499738/
  3. Jalleh RJ, Plummer MP, Marathe CS, et al. (2024). Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. The Journal of Clinical Endocrinology & Metabolism. https://pubmed.ncbi.nlm.nih.gov/39418085/
  4. Klein SR, Hobai IA. (2023). Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Canadian Journal of Anesthesia. https://pubmed.ncbi.nlm.nih.gov/36977934/

Read this as information, not instructions. WorkingMomRx is educational and never a diagnosis, a treatment plan, or a reason to start or stop a medication. A GLP-1 is a clinical decision — run it past a licensed clinician who knows your history before you act on anything here.